COVID-19 deaths in care homes: primary care management study.

IF 4.7 Q2 MATERIALS SCIENCE, BIOMATERIALS

ACS Applied Bio Materials Pub Date : 2024-12-19 DOI:10.1136/spcare-2022-003589

Clifford Wyn Jones, Liam Taylor, Aimee Clement-Rees

{"title":"COVID-19 deaths in care homes: primary care management study.","authors":"Clifford Wyn Jones, Liam Taylor, Aimee Clement-Rees","doi":"10.1136/spcare-2022-003589","DOIUrl":null,"url":null,"abstract":"Objectives: COVID-19 presented a new risk to the care home sector. Primary care adapted their approach to the management of COVID-19 in care homes as the pandemic evolved. Our aim was to evaluate the clinical presentation, management, care planning and clinical decision-making, and after death care of care home residents who died due to COVID-19 in Aneurin Bevan University Health Board in Southeast Wales.Method: Clinical records of 136 in care homes were reviewed by a General Practitioner reviewer using a standardised template. These were then reviewed by a multidisciplinary panel to identify themes.Results: Most individuals presented with 'typical' COVID-19 symptoms (cough, fever); however, >50 presented with atypical symptoms. 90% had a record of Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decision, but only 46% had documented advance care planning (ACP), and only 37% had a clearly documented treatment escalation plan.Conclusion: Care home residents are at risk of sudden clinical deterioration and death. This evaluation demonstrates that although DNACPR is in place for most individuals, holistic planning for end of life (including ACP and clinical care plans covering management of deterioration and escalation of care) is only present for a minority.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":"e2470-e2473"},"PeriodicalIF":4.7000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/spcare-2022-003589","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: COVID-19 presented a new risk to the care home sector. Primary care adapted their approach to the management of COVID-19 in care homes as the pandemic evolved. Our aim was to evaluate the clinical presentation, management, care planning and clinical decision-making, and after death care of care home residents who died due to COVID-19 in Aneurin Bevan University Health Board in Southeast Wales.

Method: Clinical records of 136 in care homes were reviewed by a General Practitioner reviewer using a standardised template. These were then reviewed by a multidisciplinary panel to identify themes.

Results: Most individuals presented with 'typical' COVID-19 symptoms (cough, fever); however, >50 presented with atypical symptoms. 90% had a record of Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) decision, but only 46% had documented advance care planning (ACP), and only 37% had a clearly documented treatment escalation plan.

Conclusion: Care home residents are at risk of sudden clinical deterioration and death. This evaluation demonstrates that although DNACPR is in place for most individuals, holistic planning for end of life (including ACP and clinical care plans covering management of deterioration and escalation of care) is only present for a minority.

查看原文本刊更多论文

COVID-19 护理院死亡案例：初级护理管理研究。

目标：COVID-19 给护理院带来了新的风险。随着大流行病的发展，基层医疗机构调整了对护理院中 COVID-19 的管理方法。我们的目的是评估威尔士东南部 Aneurin Bevan 大学健康委员会中因 COVID-19 而死亡的护理院居民的临床表现、管理、护理计划和临床决策以及死后护理：方法：由一名全科医生审查员使用标准化模板对护理院中的 136 份临床记录进行审查。然后由一个多学科小组进行审查，以确定主题：结果：大多数人表现出 "典型 "的 COVID-19 症状（咳嗽、发烧），但也有超过 50 人表现出非典型症状。90%的人有不尝试心肺复苏（DNACPR）的决定记录，但只有46%的人有预先护理计划（ACP）的记录，只有37%的人有明确记录的治疗升级计划：结论：护理院居民面临着临床病情突然恶化和死亡的风险。这项评估表明，虽然大多数人都已实施了 "生命终止预案"（DNACPR），但只有少数人制定了生命终结的整体规划（包括 ACP 和涵盖病情恶化管理和护理升级的临床护理计划）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Applied Bio Materials Chemistry-Chemistry (all)

CiteScore

9.40

自引率

2.10%

发文量

464

期刊介绍： ACS Applied Bio Materials is an interdisciplinary journal publishing original research covering all aspects of biomaterials and biointerfaces including and beyond the traditional biosensing, biomedical and therapeutic applications. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrates knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important bio applications. The journal is specifically interested in work that addresses the relationship between structure and function and assesses the stability and degradation of materials under relevant environmental and biological conditions.